GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,627 | -1,094 | 471 | 191 | 311 |
| Depreciation Amortization | 373 | 207 | 851 | 673 | 450 |
| Accounts receivable | -122 | -55 | 14 | -100 | -394 |
| Accounts payable and accrued liabilities | 676 | 174 | -49 | 13 | 7 |
| Other Working Capital | 70 | 268 | 157 | 330 | 7 |
| Other Operating Activity | 2,671 | 428 | -2,105 | -998 | -299 |
| Operating Cash Flow | $41 | $-72 | $-661 | $109 | $82 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | N/A | -132 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 3,060 | 3,060 |
| Purchase Sale Intangibles | N/A | N/A | -93 | -94 | -82 |
| Other Investing Activity | 0 | 0 | -93 | -94 | -82 |
| Investing Cash Flow | $N/A | $N/A | $-93 | $2,834 | $2,978 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -3,060 | -3,060 |
| Common Stock Issued | N/A | N/A | 500 | 500 | N/A |
| Financing Cash Flow | $N/A | $N/A | $500 | $-2,560 | $-3,060 |
| Beginning Cash Position | 191 | 1,140 | 445 | 1,208 | 1,208 |
| End Cash Position | 232 | 1,068 | 191 | 1,591 | 1,208 |
| Net Cash Flow | $41 | $-72 | $-254 | $383 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 41 | -72 | -661 | 109 | 82 |
| Free Cash Flow | 41 | -72 | -661 | 109 | 82 |